pulmonologyadvisor12h
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
MedPage Today12d
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...
2minutemedicine.com3d
Different single inhaler triple therapies appear to have similar clinical outcomes for chronic obstructive pulmonary disease
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
pharmaphorum6y
AZ boosted by COPD triple inhaler results
AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...
Hosted on MSN11d
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...
Medical Xpress8d
Study compares single-inhaler triple therapies for treatment of COPD
DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...
Monthly Prescribing Reference5d
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...